CD130/gp130 Antikörper
IL6ST
Reaktivität: Human
FACS, IP, EIA
Wirt: Maus
Monoclonal
B-K11
unconjugated
Produktnummer ABIN1105848
-
-
Target
Alle CD130/gp130 (IL6ST) Antikörper anzeigen
-
CD130/gp130 (IL6ST)
(Interleukin 6 Signal Transducer (Gp130, Oncostatin M Receptor) (IL6ST))
-
Reaktivität
-
Human
-
Wirt
-
Maus
-
Klonalität
-
Monoklonal
-
Konjugat
-
Dieser CD130/gp130 Antikörper ist unkonjugiert
-
Applikation
-
Flow Cytometry (FACS), Immunoprecipitation (IP), Enzyme Immunoassay (EIA)
-
Spezifität
-
Recognises the soluble Gp130, common subunit for IL-6, IL-11, OSM, LIF, CNTF, CT-1 receptors, a 130-140 kDa protein.
-
Aufreinigung
-
Ion exchange chromatography
-
Sterilität
-
0.22 μm filtered
-
Immunogen
-
Natural soluble gp130
-
Klon
-
B-K11
-
Isotyp
-
IgG2b
-
Top Product
-
Discover our top product IL6ST Primärantikörper
-
-
-
Applikationshinweise
-
Optimal working dilution should be determined by the investigator.
-
Beschränkungen
-
Nur für Forschungszwecke einsetzbar
-
-
Konzentration
-
1,0 mg/mL
-
Buffer
-
Phosphate-buffered saline. Sterile-filtered through 0.22 μm. Carrier and preservative free
-
Konservierungsmittel
-
Without preservative
-
Lagerung
-
4 °C
-
Informationen zur Lagerung
-
Store the antibody undiluted at 2-8 °C.
-
-
Target
-
CD130/gp130 (IL6ST)
(Interleukin 6 Signal Transducer (Gp130, Oncostatin M Receptor) (IL6ST))
-
Andere Bezeichnung
-
CD130 / IL6ST (IL6ST Produkte)
-
Synonyme
-
CD130 antikoerper, CDW130 antikoerper, GP130 antikoerper, IL-6RB antikoerper, 5133400A03Rik antikoerper, AA389424 antikoerper, BB405851 antikoerper, D13Ertd699e antikoerper, gp130 antikoerper, Ac1055 antikoerper, Gp130 antikoerper, Il-6rb antikoerper, IL-6 antikoerper, interleukin 6 signal transducer antikoerper, IL6ST antikoerper, Il6st antikoerper, il6st antikoerper
-
Hintergrund
-
Synonyms: IL-6R-beta, IL6 receptor beta, Interleukin-6 receptor subunit beta
-
Gen-ID
-
3572
-
NCBI Accession
-
NP_002175
-
UniProt
-
P40189
-
Pathways
-
JAK-STAT Signalweg, Cellular Glucan Metabolic Process, Autophagie, Smooth Muscle Cell Migration, Cancer Immune Checkpoints
-